ARGORNA

Medicines for human purposes for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Chemical-pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Drug delivery agents in the form of sterile liquid, sterile freeze-dry powder, emulsion or inhalation for medical purposes that provide controlled release of active ingredients for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Veterinary preparations for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm in cats, dogs, horses, chicken and pigs; Medicines for veterinary purposes being preparations for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm in cats, dogs, horses, chicken and pigs; Biological preparations for veterinary purposes for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm; Chemical preparations for veterinary purposes for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm; Preparations for destroying noxious animals, namely, pesticides, insecticides; Preparations for destroying noxious plants, namely, herbicides